Evaluating the Clinical Outcomes of Using Pro-Yellow Laser for Steroid-Induced Rosacea: A Prospective Clinical Study
DOI:
https://doi.org/10.54133/ajms.v9i2.2445Keywords:
Laser 577 nm, Pro-yellow laser, Rosacea, Researcher scoreAbstract
Background: Erythematotelangiectatic rosacea, face erythema, and facial telangiectasias have all been treated with different types of lasers. It has not yet been documented how well a 577-nm pro-yellow laser treats each of these disorders. Objectives: To assess the efficacy and safety of the Pro-yellow laser 577 nm in the management of rosacea. Methods: Six months, from January to July 2024, were devoted to a clinical experiment. Sixty individuals, ranging in age from twenty to sixty, were evaluated by two dermatologists for the presence of either papulopustular or erythematotelangiectatic rosacea. Two groups were formed from them: group A, which included 30 patients receiving a combination treatment that also included laser therapy, and group B, which also included 30 patients receiving a combination therapy treatment but without laser therapy. The clinician utilized the researcher's score, which is an evaluation technique with three scales: region, telangiectasia, and erythema assessment. Results: After three months, patients in group A showed a considerably greater average increase in total researcher's score, erythema, area, and telangiectasia compared to group B. After a month of treatment, group A had a greater percentage of significant improvements than group B. Group A showed a substantially greater rate of outstanding development compared to group B after three months. Conclusions: With little adverse effects, the pro-yellow laser 577 nm is a novel and efficient treatment for telangiectasia and persistent erythema in rosacea with long-lasting effect and rapid improvement of symptoms combined with conventional treatment.
Downloads
References
Türkmen D, Türkoğlu G. Demodex infestation in patients with rosacea. Turkiye Parazitolojii Dergisi. 2019;43. doi: 10.4274/tpd.galenos.2019.6456. DOI: https://doi.org/10.4274/tpd.galenos.2019.6456
Rodrigues-Braz D, Zhao M, Yesilirmak N, Aractingi S, Behar-Cohen F, Bourges JL. Cutaneous and ocular rosacea: Common and specific physiopathogenic mechanisms and study models. Mol Vis. 2021;27:323-353. PMID: 34035646.
Van Zuuren EJ. Rosacea. N Engl J Med. 2017;377(18):1754-1764. doi: 10.1056/NEJMcp1506630. DOI: https://doi.org/10.1056/NEJMcp1506630
Geng RSQ, Bourkas AN, Mufti A, Sibbald RG. Rosacea: Pathogenesis and therapeutic correlates. J Cutan Med Surg. 2024;28(2):178-819. doi: 10.1177/12034754241229365. DOI: https://doi.org/10.1177/12034754241229365
Chen C, Wang P, Zhang L, Liu X, Zhang H, Cao Y, et al. Exploring the pathogenesis and mechanism-targeted treatments of Rosacea: Previous understanding and updates. Biomedicines. 2023;11(8). doi: 10.3390/biomedicines11082153. DOI: https://doi.org/10.3390/biomedicines11082153
Baldwin HE, Harper J, Baradaran S, Patel V. Erythema of rosacea affects health-related quality of life: results of a survey conducted in collaboration with the National Rosacea Society. Dermatol Ther. 2019;9:725-734. doi: 10.1007/s13555-019-00322-5. DOI: https://doi.org/10.1007/s13555-019-00322-5
Thiboutot D, Anderson R, Cook-Bolden F, Draelos Z, Gallo RL, Granstein RD, et al. Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2020;82(6):1501-1510. doi: 10.1016/j.jaad.2020.01.077. DOI: https://doi.org/10.1016/j.jaad.2020.01.077
Sharma A, Kroumpouzos G, Kassir M, Galadari H, Goren A, Grabbe S, et al. Rosacea management: a comprehensive review. J Cosmet Dermatol. 2022;21(5):1895-1904. doi: 10.1111/jocd.14816. DOI: https://doi.org/10.1111/jocd.14816
Hampton P, Berth‐Jones J, Duarte Williamson C, Hay R, Leslie T, Porter I, et al. British Association of Dermatologists guidelines for the management of people with rosacea 2021. Br J Dermatol. 2021;185(4):725-735. doi: 10.1111/bjd.20485. DOI: https://doi.org/10.1111/bjd.20485
Paiva-Santos AC, Gonçalves T, Peixoto D, Pires PC, Velsankar K, Jha NK, et al. Rosacea topical treatment and care: from traditional to new drug delivery systems. Molecular Pharmaceutics. 2023;20(8):3804-28. doi: 10.1021/acs.molpharmaceut.3c00324. DOI: https://doi.org/10.1021/acs.molpharmaceut.3c00324
Albahadili M, Ismael SM, Al-Samarraee MF. Is it Possible to Manage Appendicular Mass Without Surgery?. Al-Rafidain Journal of Medical Sciences. 2025 Oct 3;9(2):46-50. DOI: https://doi.org/10.54133/ajms.v9i2.2322
Temiz SA, Durmaz K, Işık B, Ataseven A, Dursun R. The effect of 577‐nm pro‐yellow laser on demodex density in patients with rosacea. J Cosmet Dermatol. 2022;21(1):242-246. doi: 10.1111/jocd.14085. DOI: https://doi.org/10.1111/jocd.14085
Yepuri V, Patil AD, Fritz K, Salavastru C, Kroumpouzos G, Nisticò SP, et al. Light-based devices for the treatment of facial erythema and telangiectasia. Dermatol Ther (Heidelb). 2021;11(6):1879-1887. doi: 10.1007/s13555-021-00607-8. DOI: https://doi.org/10.1007/s13555-021-00607-8
Altunisik N, Turkmen D, Sener S. Evaluation of the effect of 577-nm pro-yellow laser on demodex intensity. J Cosmet Laser Ther. 2021;23(7-8):221-224. doi: 10.1080/14764172.2022.2075898. DOI: https://doi.org/10.1080/14764172.2022.2075898
Mohamed EEM, Mohamed Tawfik K, Hassan Ahmad W. Successful treatment of facial vascular skin diseases with a 577‐nm pro‐yellow laser. J Cosmet Dermatol. 2019;18(6):1675-679. doi: 10.1111/jocd.12963. DOI: https://doi.org/10.1111/jocd.12963
Yang R, Liu C, Liu W, Luo J, Cheng S, Mu X. Botulinum toxin A alleviates persistent erythema and flushing in patients with erythema telangiectasia rosacea. Dermatol Ther. 2022;12(10):2285-2294. doi: 10.1007/s13555-022-00784-0. DOI: https://doi.org/10.1007/s13555-022-00784-0
Ataseven A, Temiz SA, Özer İ. An investigation of the effectiveness of the 577-nm pro-yellow laser in patients with vascular disorders. Eur J Ther. 2023;29(1). doi: 10.58600/eurjther-346. DOI: https://doi.org/10.58600/eurjther-346
Cios A, Ciepielak M, Szymański Ł, Lewicka A, Cierniak S, Stankiewicz W, et al. Effect of different wavelengths of laser irradiation on the skin cells. Int J Mol Sci. 2021;22(5):2437. doi: 10.3390/ijms22052437. DOI: https://doi.org/10.3390/ijms22052437
Kapicioglu Y, Sarac G, Cenk H. Treatment of erythematotelangiectatic rosacea, facial erythema, and facial telangiectasia with a 577-nm pro-yellow laser: a case series. Lasers Med Sci. 2019;34:93-98. doi: 10.1007/s10103-018-2606-6. DOI: https://doi.org/10.1007/s10103-018-2606-6
Aksoy Sarac G, Onder M. Evaluation of the efficacy of pro‐yellow laser in the management of vascular skin disorders. J Cosmet Dermatol. 2022;21(3). doi: 10.1111/jocd.14162. DOI: https://doi.org/10.1111/jocd.14162
Mohamed E, Younes AK, Hussein G. Efficacy of 577 nm pro-yellow laser in the treatment of melasma: a prospective split-face study. J Cosmet Laser Ther. 2020;22:1-4. doi: 10.1080/14764172.2020. DOI: https://doi.org/10.1080/14764172.2020.1744661
Sarac G, Kapicioglu Y, Cenk H. An evaluation of the efficacy of a single‐session 577 nm pro‐yellow laser treatment in patients with postacne erythema and scarring. Dermatol Ther. 2021;34(1):e14611. doi: 10.1111/dth.14611. DOI: https://doi.org/10.1111/dth.14611
Deegan AJ, Wang RK. Microvascular imaging of the skin. Physics Med Biol. 2019;64(7):07TR1. doi: 10.1088/1361-6560/ab03f1. DOI: https://doi.org/10.1088/1361-6560/ab03f1
Al-Atta DM, Al-Samarraee MF, Fadhil AA, Kadhim ST, Alsarhan HW. Compliance with second visit of diabetes mellitus screening program and impact of dietary and exercise modification on glycemic control. Al-Rafidain J Med Sci. 2025;8(2):150-156. doi: 10.54133/ajms.v8i2.1929. DOI: https://doi.org/10.54133/ajms.v8i2.1929
Zhai Q, Cheng S, Liu R, Xie J, Han X, Yu Z. Meta‐analysis of the efficacy of intense pulsed light and pulsed‐dye laser therapy in the management of rosacea. J Cosmetic Dermatol. 2024;23(12):3821-3827. doi: 10.1111/jocd.16549. DOI: https://doi.org/10.1111/jocd.16549
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Published by Al-Rafidain University College. This is an open access journal issued under the CC BY-NC-SA 4.0 license (https://creativecommons.org/licenses/by-nc-sa/4.0/).



